![]() ![]() ![]() McGovern Center for Venture Development in the Life Sciences: Jason Spector, professor of plastic surgery at Weill Cornell Medical College, will work with SteriFreeMed on a wound-healing technology, and Matthew DeLisa, professor of chemical and biomolecular engineering, is working with Glycobia Inc., to develop a method for cell-free protein synthesis. This is the first year that researchers in CAT-funded projects will collaborate with two startup companies housed in Cornell’s Kevin M. The grants, which started July 1, total $435,778 in direct funds, with an additional $689,760 in matching funds. New York state companies provide matching funds and serve as collaboration partners. The awards support Cornell life science faculty and research associates to develop biotechnologies with commercial potential. These are two of nine projects to receive one-year grants from the Center for Advanced Technology (CAT), based at Cornell’s Institute of Biotechnology. Cornell researchers and New York companies will collaborate to develop a technology that eliminates resistant microorganisms from chronic wounds to promote tissue healing, and a method of cell-free protein synthesis to spur the $120 billion protein-based therapeutics market. ![]()
0 Comments
Leave a Reply. |